THERAVANCE BIOPHARMA INC (TBPH)
KYG8807B1068 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to TBPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.71. This target is 72.24% above the current price.
TBPH was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TBPH.
In the previous month the buy percentage consensus was at a similar level.
TBPH was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-12 | BTIG | Initiate | Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-17 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-25 | Morgan Stanley | Maintains | Underweight |
| 2022-05-23 | SVB Leerink | Initiate | Outperform |
| 2022-03-02 | Morgan Stanley | Maintains | Underweight |
| 2022-02-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-05 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2021-09-16 | SVB Leerink | Maintains | Outperform |
| 2021-09-16 | Morgan Stanley | Maintains | Underweight |
| 2021-09-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-25 | Morgan Stanley | Downgrade | Overweight -> Underweight |
| 2021-08-24 | Needham | Maintains | Buy |
| 2021-08-24 | SVB Leerink | Maintains | Outperform |
| 2021-08-24 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2021-08-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-04 | SVB Leerink | Maintains | Outperform |
| 2021-07-16 | Morgan Stanley | Maintains | Overweight |
| 2021-06-28 | SVB Leerink | Maintains | Outperform |
| 2021-05-13 | Morgan Stanley | Maintains | Overweight |
| 2021-05-05 | Needham | Maintains | Buy |
| 2021-05-05 | SVB Leerink | Maintains | Outperform |
| 2021-04-01 | SVB Leerink | Maintains | Outperform |
| 2021-03-01 | Morgan Stanley | Maintains | Overweight |
| 2021-02-24 | SVB Leerink | Maintains | Outperform |